Delivery Order SPE2DB22D1017-SPE2DB26FYPGE
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,223.59 to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Xdemvy 0.25% drop in 10ml format. This is a firm fixed-price delivery order with an ultimate completion date of September 11, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,447.18 to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Xdemvy 0.25% drop in 10ml quantities. This is a firm fixed price delivery order with an ultimate completion date of October 15, 2025, to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The Defense Logistics Agency awarded a $1,223.59 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Xdemvy 0.25% drop in a 10ml formulation. This firm fixed price delivery order, which is not associated with a set-aside program, will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 9, 2025. The award represents a child contract under AmerisourceBergen's larger indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of XDEMVY 0.25% DROP 10ML pharmaceutical product. This firm fixed-price delivery order has a ceiling value of $1,223.59 and is scheduled for completion by October 16, 2025. The contract is being performed in Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters, and does not utilize a set-aside designation. As a child contract, this...
- The Defense Logistics Agency awarded a delivery order valued at $1,223.59 to AmerisourceBergen Drug Corp for XDEMVY 0.25% drop in 10ml quantities under a firm fixed price contract. The award was issued on August 28, 2025, with an ultimate completion date of September 19, 2025. This non-competitive delivery order represents a child contract executed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $3,670.77 to AmerisourceBergen Drug Corp on July 22, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order is for XDEMVY 0.25% DROP 10ML pharmaceutical product and will be performed in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. The award involved no set-aside designation and was competitively awarded to the vendor. This...
- The Defense Logistics Agency awarded a $1,223.59 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for XDEMVY 0.25% drop in 10ml format. This is an unset-aside, competitively awarded delivery order with an ultimate completion date of October 15, 2025, to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery order leverages AmerisourceBergen's existing capacity...
- The Defense Logistics Agency awarded a delivery order valued at $1,223.59 to AmerisourceBergen Drug Corp for XDEMVY 0.25% Drop 10ML, with an ultimate completion date of August 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning the award was competitively competed. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,223.59 delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of XDEMVY 0.25% Drop in a 10 mL formulation, with an ultimate completion date of August 22, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for XDEMVY 0.25% Drop 10ML pharmaceutical product. This firm fixed-price delivery order, valued at $1,223.59, represents a competitively awarded contract with no set-aside designation and an ultimate completion date of August 14, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB26FYPGEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,223.59 to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Xdemvy 0.25% Drop in 10ml quantities. This is a firm fixed price, competitively awarded delivery order with a completion date of November 6, 2025, with performance to take place in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, serves as a critical vendor for federal medical procurement across the Defense Health Agency, U.S. military, and other government healthcare systems. The company's federal contract portfolio demonstrates extensive capability in delivering a wide range of pharmaceutical products and medical supplies, including both brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 10/16/25 |